The lawsuit asks the courts to nullify the Trump administration’s decision to reduce the childhood vaccine schedule.

At 48 weeks, 1% of participants in both groups had an HIV-1 RNA level of 50 copies per milliliter or higher, meeting the prespecified noninferiority margin of 4%. Rates of viral suppression below 50 ...

British immunotherapy company Centauri Therapeutics received a ₤6 million ($8.1 million USD) investment from the AMR Action Fund to support development of its broad-spectrum antibiotic candidate, ...

A Public Health Alerts report today describes the first known US multistate outbreak of infant botulism tied to powdered infant formula, identifying a clear link between illness in dozens of infants ...

HHS administers nearly $900 million annually through the Public Health Emergency Preparedness (PHEP) program and the Hospital ...

This is part 2 in a three-part series on potential harms from taking antibiotics for dental procedures. Part 3 will publish tomorrow and Thursday. All will be available here. About once a week, Erinne ...

South Carolina has been by far the hardest-hit state this year, with 632 CDC-confirmed cases, followed by Utah (117), Florida (64), and Arizona (36). Positive samples were significantly more common in ...

An analysis involving more than 12.4 million US newborns shows that after six years of growth, receipt of the hepatitis B virus (HBV) vaccine birth dose fell more than 10 percentage points in the past ...

The measles outbreak in South Carolina reached 979 cases today, but its growth seems to be slowing. Only six new cases were reported by the South Carolina Department of Public Health (DPH) in an ...

Officials in Guinea-Bissau have stopped a controversial, US government-funded clinical trial examining the side effects of the hepatitis B vaccine, according to media reports.

Dentists wrote more than 2.3 million prescriptions last year for an antibiotic called clindamycin, whose label has carried a ...

A single dose of mRNA-1073 elicited durable immune responses through 6 months against all vaccine-matched influenza and SARS-CoV-2 strains.